21
Views
12
CrossRef citations to date
0
Altmetric
Section II: Clinical and Toxicological Considerations

Schizophreniform Psychosis Induced by Large-Dose Administration of d-Amphetamine

, &
Pages 25-27 | Published online: 02 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

JohnB. Murray. (1998) Psychophysiological Aspects of Amphetamine-Methamphetamine Abuse. The Journal of Psychology 132:2, pages 227-237.
Read now
DonaldR. Wesson & DavidE. Smith. (1978) A Clinical Approach to Diagnosis and Treatment of Amphetamine Abuse. Journal of Psychedelic Drugs 10:4, pages 343-350.
Read now
BurtonM. Angrist & Samuel Gershon. (1969) Amphetamine Abuse in New York City 1966 to 1968. Journal of Psychedelic Drugs 2:2, pages 84-91.
Read now
DavidE. Smith. (1969) An Analysis of Variables in High Dose Methamphetamine Dependence. Journal of Psychedelic Drugs 2:2, pages 60-62.
Read now
JohnC. Kramer. (1969) Introduction to Amphetamine Abuse. Journal of Psychedelic Drugs 2:2, pages 8-13.
Read now

Articles from other publishers (7)

Kevin A. Sevarino & Bryan C. Shelby. 2015. Psychiatry. Psychiatry 1561 1614 .
Suzette Glasner-Edwards & Larissa J. Mooney. (2014) Methamphetamine Psychosis: Epidemiology and Management. CNS Drugs 28:12, pages 1115-1126.
Crossref
Chih-Ken Chen & Robin M. Murray. 2010. Neurodevelopment and Schizophrenia. Neurodevelopment and Schizophrenia 248 270 .
LYNNE SMITH, M. LYNN YONEKURA, TONI WALLACE, NANCY BERMAN, JENNIFER KUO & CAROL BERKOWITZ. (2003) Effects of Prenatal Methamphetamine Exposure on Fetal Growth and Drug Withdrawal Symptoms in Infants Born at Term. Journal of Developmental & Behavioral Pediatrics 24:1, pages 17-23.
Crossref
David E. Smith & Richard B. Seymour. 1986. Topics in Clinical Pharmacology and Therapeutics. Topics in Clinical Pharmacology and Therapeutics 477 493 .
Charles R. Schuster & Marian W. Fischman. 1975. Behavioral Pharmacology. Behavioral Pharmacology 181 194 .
Rue L. Cromwell. (1972) Strategies for studying schizophrenic behavior. Psychopharmacologia 24:1, pages 121-146.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.